Axonics Modulation Technologies (AXNX)
NASDAQ:AXNX
Holding AXNX?
Track your performance easily

Axonics Modulation Technologies (AXNX) Ownership - Who Owns Axonics Modulation Technologies?

239 Followers

Axonics Modulation Technologies (AXNX) Ownership Overview

1.12%22.98%8.05%18.64%49.21%
8.05% Other Institutional Investors
18.64% ETFs
49.21% Public Companies and
Individual Investors
The ownership structure of Axonics Modulation Technologies (AXNX) stock is a mix of institutional, retail, and individual investors. Approximately 49.67% of the company’s stock is owned by Institutional Investors, 1.12% is owned by Insiders, and 49.21% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 03, 2024
xxxxxxxxxxxxx
$205493

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$336150
Jun 30, 2024
xxxxxxxxxxxxx
$831231
Jun 30, 2024
xxxxxxxxxxxxx
$2185580
Jun 30, 2024
xxxxxxxxxxxxx
$2865275

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,855,501Institution9.50%341,924,380
4,377,252Institution8.56%308,246,086
2,353,425Institution4.60%165,728,189
1,909,697Institution3.74%134,480,863
1,774,842Institution3.47%124,984,374
1,274,597Institution2.49%89,757,121
1,027,879Institution2.01%72,383,239
569,253Institution1.11%40,086,796
531,243Institution1.04%37,410,132
521,470Institution1.02%36,721,917

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,377,252Institution8.56%308,246,086
1,909,697Institution3.74%134,480,863
1,027,879Institution2.01%72,383,239
569,253Institution1.11%40,086,796
531,243Institution1.04%37,410,132
521,470Institution1.02%36,721,917
477,333Institution0.93%33,613,790
463,615Institution0.91%32,647,768
342,018Institution0.67%24,084,908
258,371Institution0.51%18,194,486

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,634,436Institution3.20%113,756,746
1,386,511Institution2.71%97,638,105
1,279,294Institution2.50%89,038,862
740,733Institution1.45%51,555,017
705,684Institution1.38%49,115,606
560,752Institution1.10%39,504,978
560,752Institution1.10%39,504,978
457,061Institution0.89%32,186,236
291,554Institution0.57%20,531,233
246,312Institution0.48%17,352,680

FAQ

Who Owns Axonics Modulation Technologies (AXNX)?
According to the latest TipRanks data, approximately 8.05% of the company's stock is held by institutional investors, 1.12% is held by insiders, and 49.21% is held by retail investors.
    What percentage of Axonics Modulation Technologies (AXNX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 8.05% of Axonics Modulation Technologies (AXNX) stock is held by institutional investors.
      What percentage of Axonics Modulation Technologies (AXNX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 49.21% of Axonics Modulation Technologies (AXNX) stock is held by retail investors.
        Who owns the most shares of Axonics Modulation Technologies (AXNX)?
        Vanguard owns the most shares of Axonics Modulation Technologies (AXNX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis